Why is Syncom Formul. falling/rising?

As of 10-Jun, Syncom Formulations (India) Ltd is experiencing a price increase, currently at 22.03, which reflects a rise of 0.6 or 2.8%. The stock has shown strong performance recently, outperforming its sector by 2.28% today and achieving a consecutive gain over the last two days with a total return of 5.66%. Additionally, the stock has been trading above its moving averages across various time frames, indicating positive momentum. Over the past year, it has generated an impressive return of 82.52%, significantly outperforming the BSE 500 index in both the short and long term. The company's financial health is also a contributing factor, with a low debt-to-equity ratio and substantial growth in net profit and sales, which have increased by 36.08% and 97.85%, respectively.
In the broader market context, Syncom Formulations has outperformed the Sensex, which has only risen by 2.05% over the past week, while the stock has increased by 4.16% in the same period. This trend of outperformance is consistent, as the stock has shown a remarkable 155.57% increase over the last three years compared to the benchmark's 51.72%. The rising investor participation, evidenced by an 18.25% increase in delivery volume, further supports the stock's upward movement, indicating strong market interest and liquidity. Overall, the combination of solid financial results, positive market sentiment, and strong relative performance against benchmarks has contributed to the stock's rising price.